HPM Seminar Series
HSRP&A PhD Student
Division of Health Policy & Management
Opioid abuse is a serious and growing issue in the U.S., one specific population affected is pregnant women. It is important to treat pregnant women with opioid abuse because opioid abuse during pregnancy will significantly increase: adverse maternal outcomes (stillbirth, preterm birth, mortality), morbidity in infants (neonatal abstinence syndrome), and long-term healthcare utilization. For some women, prenatal care during pregnancy is the first or only time that they will encounter routine clinical care. Therefore, screening for opioid abuse during prenatal visits is the ideal time to identify and refer women with opioid abuse to treatment. Routine screening for, and treatment of, opioid abuse during pregnancy is extremely feasible and recommended. However, variation in practice and insurance coverage, limits the number of pregnant women who are screened for opioid abuse and referred to treatment. In this study, Thao uses a decision analytic model to identify a best-value screen-and-treat strategy for pregnant women with opioid abuse. Results from this study will inform clinical practice on the frequency of which clinicians should screen for opioid abuse, the screening tool that should be used, and the line of treatment that should be recommended. Results from this study will also inform payers on the costs associated with various screen and treat strategies for opioid abuse during pregnancy.
All are welcome to attend. Light refreshments served.
Unfortunately, we are unable to live stream this seminar